NCCN=National Comprehensive Cancer Network.

Efficacy data

Discover efficacy data from EXPLORER and PATHFINDER1

Pie chart

Explore the safety and tolerability of AYVAKIT1

Medicine bottle

Access dosing information for patients on treatment with AYVAKIT

Patient clipboard

See how hypothetical patients may respond to treatment for Advanced SM

Targeted AdvSM treatment

The ONLY treatment to selectively target the underlying mutation1

Avapritinib is a tyrosine kinase inhibitor designed for the potent and selective inhibition of KIT D816V—the underlying driver of disease in ~95% of cases.1,3-6

Dr. Ruben Mesa video

Learn more from your peers by exploring the AYVAKIT Expert Series Video Library

Watch Now
Dr Ruben Mesa

Sign up to receive updates on AYVAKIT for Advanced SM and connect with a representative

All fields required unless otherwise noted.

To learn more about Blueprint Medicines' privacy practices, including how we process, share, and protect your Personal Information, please read our Privacy Notice.

Oops! We're missing key information we need to connect with you.

Submit